Publication | Description | Treatment (n) | Fever clearance | Parasite clearance | Cure rate |
---|---|---|---|---|---|
McGready et al. , 2008[22] | Thai study. Open- label, randomized study of AL vs. AS in the 2nd and 3rd trimesters | AL (125) | 2 (1–3) days†| 2 (1–5) days†| 87.2% (95% CI 81.1–93.2)‡ at Day 42.82.0% (95% CI 74.8–89.3)‡ at delivery (or Day 42 if later) |
 |  | AS (128) | 1 (1–2) days†| 2 (1–5) days†| 95.2% (95% CI 91.5–97.1)‡ at Day 42.89.2% (95% CI 82.3–96.1)‡ at delivery (or Day 42 if later) |
Kaye et al. , 2008[23] | Ugandan study. Open-label, randomized study of AL vs. chlorproguanil-dapsone* in the 2nd and 3rd trimesters | AL (58) | 47 (85.5%) clear at Day 2 | 49 (89.1%) clear at Day 2 | 100% at Day 28 |
Piola et al., 2010[25] | Ugandan study. Open-label, randomized study of AL vs. Q in the 2nd and 3rd trimesters | AL (152) | 130 (100%) clear at Day 2 | 148 (99%) clear at Day 2 | 99.3% (range 96.0–99.9)§ at Day 42.98.2% (range 93.5–99.7)§ at delivery (or Day 42 if later) |
 |  | Q (152) | 127 (99%) clear at Day 2 | 123 (86%) clear at Day 2 | 97.6% (range 93.1–99.5)§ at Day 42.96.1% (range 90.2–98.9)§ at delivery (or Day 42 if later) |